Nurse Practitioner, Family · Mason, OH
NPI
1437499076
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
969 Reading Rd Ste N
Mason, OH, 45040
Phone (513) 604-1004
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
610 services
Medicare patients, 2024
146
Average age 72
Drug cost, 2024
$1.8M
3,985 prescriptions
Company payments, 2025
$2,753
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Spivak was code 99214 (office e&m - established), 299 times for 136 patients. In total Michael Spivak billed 610 services in 11 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 299 | 136 | $69.15 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 208 | 107 | $9.67 | $2,012 |
| 95251 Test - Miscellaneous | Office | 62 | 26 | $19.01 | $1,179 |
| 99215 Office E&M - Established | Office | 17 | 14 | $104.23 | $1,772 |
By year: 2022 $4,012 for 76 services; 2023 $9,083 for 151 services; 2024 $27K for 610 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael Spivak prescribed most often to Medicare patients was Levothyroxine Sodium, with 353 prescriptions and refills. In total Michael Spivak wrote 3,985 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 353 | 842 | 83 | $2,518 |
| Rosuvastatin Calcium Generic | 150 | 416 | 45 | $1,711 |
| Ozempic Semaglutide | 136 | 169 | 25 | $143K |
| Metformin Hcl Er Metformin Hcl | 127 | 373 | 43 | $1,226 |
| Trulicity Dulaglutide | 126 | 211 | 26 | $210K |
| Synthroid Levothyroxine Sodium | 106 | 278 | 28 | $9,357 |
| Jardiance Empagliflozin | 106 | 193 | 28 | $113K |
| Ezetimibe Generic | 86 | 234 | 24 | $2,017 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 82 | 157 | 22 | $13K |
| Repaglinide Generic | 81 | 154 | 17 | $974 |
| Atorvastatin Calcium Generic | 81 | 243 | 23 | $689 |
| Liothyronine Sodium Generic | 80 | 198 | 23 | $3,104 |
| Farxiga Dapagliflozin Propanediol | 70 | 137 | 12 | $75K |
| Metformin Hcl Generic | 69 | 189 | 20 | $508 |
| Gabapentin Generic | 67 | 119 | 16 | $713 |
Brand drugs: 1,558 claims; generic drugs: 2,216 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Spivak $2,753 ($2,753 in general payments such as food, travel and fees) from 29 companies. The largest payer was Lilly USA, LLC with $268.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 17 | $268 |
| Kyowa Kirin, Inc. 4151.T | 8 | $248 |
| Novo Nordisk Inc NVO | 16 | $229 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $190 |
| Amgen Inc. AMGN | 9 | $164 |
| Recordati_rare_diseases_inc. | 7 | $158 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $149 |
| Abbvie Inc. ABBV | 12 | $140 |
| Beta Bionics, Inc. BBNX | 5 | $112 |
| Insulet Corporation PODD | 5 | $89.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.